Forest Neurotech is developing a novel ultrasound-based brain-computer interface (BCI) designed to sense and modulate the whole brain without penetrating tissue. The technology aims to provide a minimally invasive platform for diagnostics, monitoring, and therapeutics across the entire brain, addressing limitations of invasive, region-limited BCIs. Potential applications cited include mitigating seizures and treating severe depression. Forest operates as a Focused Research Organization (FRO), a non-profit startup model pioneered by Convergent Research, and intends to share its tools, research, and discoveries with the broader scientific community. The initiative was founded by Sumner Norman, Tyson Aflalo, and Will Biederman and leverages recent advances in ultrasound neurotechnologies. Financially, Forest has received philanthropic funding commitments, including a notable $14 million commitment from Eric Schmidt and additional support from other philanthropies and individuals.

Total raised

$14M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2024